robcarroll
Nov 20, 2:02 PM
$SLS Think about who just bought and when.
A J.P. Morgan and TD Cowen book placed 11.5M shares at
$13 with institutional accounts. That is the level where funds were willing to write
$150M of checks, after seeing the full REGAL topline, and the stock has traded above it every day since.
Look at the timing. They put the money in before ASH on Dec 12 to 15, before the SLS009 newly diagnosed AML readout due this quarter, and before the J.P. Morgan Healthcare Conference in January. They positioned ahead of the catalysts, not after.
Look at the terms. The 60 day lock-up on the company and insiders, plus the ATM being off limits until it expires, exists for one reason: to protect the buyers at
$13 from new supply while those catalysts play out. Nobody negotiates that protection for a window they expect to be quiet.
$275M in cash, zero new shares for 60 days, and the people who just committed
$150M are sitting on a gain. That is the setup going into ASH.
$XBI $IBB
3 replies